Logo image of HEPS

D-MARKET ELECTRONIC SERV-ADR (HEPS) Stock Fundamental Analysis

NASDAQ:HEPS - Nasdaq - US23292B1044 - ADR - Currency: USD

2.69  -0.11 (-3.93%)

After market: 2.8 +0.11 (+4.09%)

Fundamental Rating

3

HEPS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 31 industry peers in the Broadline Retail industry. The financial health of HEPS is average, but there are quite some concerns on its profitability. While showing a medium growth rate, HEPS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HEPS had negative earnings in the past year.
HEPS had a positive operating cash flow in the past year.
In the past 5 years HEPS reported 4 times negative net income.
Of the past 5 years HEPS 4 years had a positive operating cash flow.
HEPS Yearly Net Income VS EBIT VS OCF VS FCFHEPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2B -2B 4B

1.2 Ratios

Looking at the Return On Assets, with a value of -6.54%, HEPS is doing worse than 61.29% of the companies in the same industry.
HEPS's Return On Equity of -43.66% is on the low side compared to the rest of the industry. HEPS is outperformed by 67.74% of its industry peers.
Industry RankSector Rank
ROA -6.54%
ROE -43.66%
ROIC N/A
ROA(3y)-11.34%
ROA(5y)-14.4%
ROE(3y)-45.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HEPS Yearly ROA, ROE, ROICHEPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 -50

1.3 Margins

HEPS has a worse Gross Margin (35.27%) than 64.52% of its industry peers.
HEPS's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for HEPS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.14%
GM growth 5Y6.31%
HEPS Yearly Profit, Operating, Gross MarginsHEPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20 30

More info and screens

5

2. Health

2.1 Basic Checks

HEPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HEPS has more shares outstanding
HEPS has less shares outstanding than it did 5 years ago.
HEPS has a better debt/assets ratio than last year.
HEPS Yearly Shares OutstandingHEPS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 100M 200M 300M
HEPS Yearly Total Debt VS Total AssetsHEPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 2.63 indicates that HEPS is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.63, HEPS is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
HEPS has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
HEPS's Debt to FCF ratio of 0.35 is amongst the best of the industry. HEPS outperforms 93.55% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that HEPS is not too dependend on debt financing.
HEPS has a Debt to Equity ratio (0.44) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.35
Altman-Z 2.63
ROIC/WACCN/A
WACC30.18%
HEPS Yearly LT Debt VS Equity VS FCFHEPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.02 indicates that HEPS should not have too much problems paying its short term obligations.
With a Current ratio value of 1.02, HEPS is not doing good in the industry: 90.32% of the companies in the same industry are doing better.
A Quick Ratio of 0.66 indicates that HEPS may have some problems paying its short term obligations.
HEPS's Quick ratio of 0.66 is on the low side compared to the rest of the industry. HEPS is outperformed by 80.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.66
HEPS Yearly Current Assets VS Current LiabilitesHEPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5B 10B 15B

More info and screens

6

3. Growth

3.1 Past

The earnings per share for HEPS have decreased strongly by -573.59% in the last year.
Looking at the last year, HEPS shows a very strong growth in Revenue. The Revenue has grown by 149.58%.
HEPS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 78.63% yearly.
EPS 1Y (TTM)-573.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.71%
Revenue 1Y (TTM)149.58%
Revenue growth 3Y77.34%
Revenue growth 5Y78.63%
Sales Q2Q%57.93%

3.2 Future

Based on estimates for the next years, HEPS will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.11% on average per year.
HEPS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 44.58% yearly.
EPS Next Y-134.57%
EPS Next 2Y3.17%
EPS Next 3Y19.11%
EPS Next 5YN/A
Revenue Next Year75.07%
Revenue Next 2Y55.2%
Revenue Next 3Y44.58%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HEPS Yearly Revenue VS EstimatesHEPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 20B 40B 60B 80B
HEPS Yearly EPS VS EstimatesHEPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

HEPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 33.45 indicates a quite expensive valuation of HEPS.
HEPS's Price/Forward Earnings is on the same level as the industry average.
HEPS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.38.
Industry RankSector Rank
PE N/A
Fwd PE 33.45
HEPS Price Earnings VS Forward Price EarningsHEPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as HEPS.
Based on the Price/Free Cash Flow ratio, HEPS is valued cheaper than 87.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.86
EV/EBITDA 19.68
HEPS Per share dataHEPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

HEPS's earnings are expected to grow with 19.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.17%
EPS Next 3Y19.11%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HEPS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

D-MARKET ELECTRONIC SERV-ADR

NASDAQ:HEPS (4/28/2025, 8:14:07 PM)

After market: 2.8 +0.11 (+4.09%)

2.69

-0.11 (-3.93%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)12-10 2024-12-10/bmo
Earnings (Next)N/A N/A
Inst Owners14.19%
Inst Owner Change0.13%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap876.94M
Analysts82.22
Price Target4.23 (57.25%)
Short Float %2.82%
Short Ratio3.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)6.41%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-114.89%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 33.45
P/S 0.54
P/FCF 6.86
P/OCF 5.08
P/B 9.19
P/tB 36.79
EV/EBITDA 19.68
EPS(TTM)-0.13
EYN/A
EPS(NY)0.08
Fwd EY2.99%
FCF(TTM)0.39
FCFY14.59%
OCF(TTM)0.53
OCFY19.7%
SpS5.02
BVpS0.29
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.54%
ROE -43.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.27%
FCFM 7.82%
ROA(3y)-11.34%
ROA(5y)-14.4%
ROE(3y)-45.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.14%
GM growth 5Y6.31%
F-Score4
Asset Turnover2.57
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.35
Debt/EBITDA 1
Cap/Depr 94.74%
Cap/Sales 2.74%
Interest Coverage N/A
Cash Conversion 413.77%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.66
Altman-Z 2.63
F-Score4
WACC30.18%
ROIC/WACCN/A
Cap/Depr(3y)121.47%
Cap/Depr(5y)110.53%
Cap/Sales(3y)3.7%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-573.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.71%
EPS Next Y-134.57%
EPS Next 2Y3.17%
EPS Next 3Y19.11%
EPS Next 5YN/A
Revenue 1Y (TTM)149.58%
Revenue growth 3Y77.34%
Revenue growth 5Y78.63%
Sales Q2Q%57.93%
Revenue Next Year75.07%
Revenue Next 2Y55.2%
Revenue Next 3Y44.58%
Revenue Next 5YN/A
EBIT growth 1Y79.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year252.1%
EBIT Next 3Y95.44%
EBIT Next 5YN/A
FCF growth 1Y411.4%
FCF growth 3Y124.57%
FCF growth 5Y100.63%
OCF growth 1Y855.4%
OCF growth 3Y124.87%
OCF growth 5Y97.22%